China Dasheng Biotechnology Performance
| CDBTDelisted Stock | USD 0.04 0.00 0.00% |
The firm shows a Beta (market volatility) of 7.7, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, China Dasheng will likely underperform. China Dasheng Biotec right now shows a risk of 0.0%. Please confirm China Dasheng Biotec total risk alpha, as well as the relationship between the potential upside and kurtosis , to decide if China Dasheng Biotec will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days China Dasheng Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, China Dasheng is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Price Earnings Ratio | 1.25 | |
| Total Cashflows From Investing Activities | -3.9 M |
China |
China Dasheng Relative Risk vs. Return Landscape
If you would invest 4.24 in China Dasheng Biotechnology on November 16, 2025 and sell it today you would earn a total of 0.00 from holding China Dasheng Biotechnology or generate 0.0% return on investment over 90 days. China Dasheng Biotechnology is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than China, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
China Dasheng Target Price Odds to finish over Current Price
The tendency of China Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.04 | 90 days | 0.04 | about 66.71 |
Based on a normal probability distribution, the odds of China Dasheng to move above the current price in 90 days from now is about 66.71 (This China Dasheng Biotechnology probability density function shows the probability of China Pink Sheet to fall within a particular range of prices over 90 days) .
China Dasheng Price Density |
| Price |
Predictive Modules for China Dasheng
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as China Dasheng Biotec. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.China Dasheng Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. China Dasheng is not an exception. The market had few large corrections towards the China Dasheng's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold China Dasheng Biotechnology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of China Dasheng within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 7.23 | |
β | Beta against Dow Jones | 7.70 | |
σ | Overall volatility | 0.03 | |
Ir | Information ratio | 0.15 |
China Dasheng Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of China Dasheng for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for China Dasheng Biotec can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| China Dasheng Biotec is not yet fully synchronised with the market data | |
| China Dasheng Biotec has some characteristics of a very speculative penny stock | |
| China Dasheng Biotec has a very high chance of going through financial distress in the upcoming years |
China Dasheng Fundamentals Growth
China Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of China Dasheng, and China Dasheng fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on China Pink Sheet performance.
| Return On Equity | 0.39 | |||
| Return On Asset | 0.2 | |||
| Profit Margin | 0.31 % | |||
| Operating Margin | 0.34 % | |||
| Current Valuation | 8.1 M | |||
| Price To Earning | 0.33 X | |||
| Price To Book | 0.47 X | |||
| Price To Sales | 0.17 X | |||
| Revenue | 16.29 M | |||
| EBITDA | 7.72 M | |||
| Cash And Equivalents | 10.41 M | |||
| Cash Per Share | 0.35 X | |||
| Total Debt | 1.46 M | |||
| Book Value Per Share | 0.64 X | |||
| Cash Flow From Operations | 4.1 M | |||
| Earnings Per Share | 0.03 X | |||
| Total Asset | 20.25 M | |||
| Retained Earnings | 14.21 M | |||
| Current Asset | 14.77 M | |||
| Current Liabilities | 2.23 M | |||
About China Dasheng Performance
Assessing China Dasheng's fundamental ratios provides investors with valuable insights into China Dasheng's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the China Dasheng is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
China Dasheng Biotechnology Company, together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the Peoples Republic of China. China Dasheng Biotechnology Company is based in Lanzhou, China. China Dasheng is traded on OTC Exchange in the United States.Things to note about China Dasheng Biotec performance evaluation
Checking the ongoing alerts about China Dasheng for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for China Dasheng Biotec help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| China Dasheng Biotec is not yet fully synchronised with the market data | |
| China Dasheng Biotec has some characteristics of a very speculative penny stock | |
| China Dasheng Biotec has a very high chance of going through financial distress in the upcoming years |
- Analyzing China Dasheng's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether China Dasheng's stock is overvalued or undervalued compared to its peers.
- Examining China Dasheng's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating China Dasheng's management team can have a significant impact on its success or failure. Reviewing the track record and experience of China Dasheng's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of China Dasheng's pink sheet. These opinions can provide insight into China Dasheng's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in China Pink Sheet
If you are still planning to invest in China Dasheng Biotec check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Dasheng's history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |